Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ElitePhysiqMD vs LillyDirect Foundayo

ElitePhysiqMD
Graded #154

Higher grade

vs+0.5999999999999943
LillyDirect Foundayo
Graded #165

Lower grade

The verdict

ElitePhysiqMD takes it — 67.8/100 to 67.2/100, but only just.

ElitePhysiqMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. ElitePhysiqMD is a physician-led telehealth platform prescribing compounded semaglutide (from $145/mo) and tirzepatide (from $315/mo subscription) to patients in all 50 states. LillyDirect Foundayo is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueElitePhysiqMD +3
75
72
Dose & formulationElitePhysiqMD +5
64
59
Clinical oversightElitePhysiqMD +1
79
78
Labs & monitoringEven
52
52
FulfillmentLillyDirect Foundayo +11
69
80
Contract termsEven
55
55
ElitePhysiqMD · left barLillyDirect Foundayo · right bar

The numbers

MetricElitePhysiqMDLillyDirect Foundayo
WeighScore67.8/10067.2/100
GradeCC
Scorecard rank#154#165
Semaglutide$145/mo (starting dose, compounded)Not disclosed
Tirzepatide$315/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
ElitePhysiqMD

Graded #154 · C

Strengths

  • Compounded semaglutide from $145/mo subscription with no video calls and cancel-anytime policy
  • LegitScript certified, HIPAA-compliant; prescriptions from board-certified physicians via 5-min online assessment
  • Medications from US-licensed 503A/503B compounding pharmacies, shipped discreetly in 5–7 business days
  • HSA/FSA eligible; accepts all 50 states with no insurance required
  • Peptide therapy also available: NAD+, sermorelin, CJC-1295/ipamorelin, GHK-Cu, and glutathione

Where it loses points

  • Required $49 telehealth visit is added to every order, increasing effective monthly cost above the headline price
  • No labs disclosed; medication plans don't appear to include bloodwork or baseline testing
  • No dietitian, coaching, or nutrition support mentioned; program is medication-only
  • Tirzepatide subscription price ($315/mo) is above the mid-range for compounded tirzepatide
  • Newer platform (founded late 2025); no Trustpilot rating or public patient reviews found
LillyDirect Foundayo

Graded #165 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard